Computational modeling of GPCRs: understanding receptor signaling for biology and drug discovery by Katritch, Vsevolod Seva
  
 77 
Severo Ochoa Research Seminar - BSC 
2017-2018 
 
July 13th, 2018 
  
Computational Modeling of GPCRs: Understanding Receptor 
Signaling for Biology and Drug Discovery 
 
 
Vsevolod “Seva” Katritch,  
University of Southern California 
 
Abstract  
Recent advances in crystallography and cryo-EM have led to structure determination for 
more than fifty G-protein coupled receptors (GPCRs), covering most branches of this 
therapeutically important 7-transmembrane superfamily of more than 800 proteins. The 
structures provide a solid 3D framework for computational studies of GPCR molecular 
interactions with ligands and allosteric modulators, characterization of their functional 
states and complexes with downstream effectors, as well as a platform for structure-
based ligand discovery.  
 
In this talk I will describe several new computational approaches to GPCR modelling and 
design developed in my lab. To predict stabilizing mutations in GPCRs we have 
developed a CompoMug tool as combination of sequence-based analysis, structural 
information, and a derived machine learning predictor1. Novel insights into the GPCR 
functional mechanisms can be also obtained by structural bioinformatics and molecular 
dynamics characterization of the protein and its allosteric co-factors, including highly 
conserved sodium ion and water cluster in the center of the 7TM bundle in Class A 
GPCRs2,3.  Finally, structural pharmacology analysis of the orthosteric and allosteric 
ligand binding sites helps to explain selectivity and functional profiles of known drugs 
and drug candidates4,5.  Applied to the key receptors in inflammation and pain 
perception pathways, including opioid, cannabinoid and angiotensin receptors, these 
approaches give a powerful tool for virtual screening and rational design of novel GPCR 
ligands with desirable functional features as molecular probes and lead candidates. 
 
1Popov et al. (2018) Rational design of thermostabilizing mutations for G-protein 
coupled receptors. eLife, in press. 
2Katritch et al. (2014) Allosteric sodium in class A GPCR signaling. Trends Biochem Sci. 
39(5):233-44.  
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3Vickery et al. (2018) Intracellular Transfer of Na(+) in an Active-State G-Protein-
Coupled Receptor. Structure 26:171 
4Zheng et al. (2017) Structure-Based Discovery of New Antagonist and Biased Agonist 
Chemotypes for the Kappa Opioid Receptor. J Med Chem. 60(7):3070-81.  
5Zhang et al. (2017). Structural basis for selectivity and diversity in angiotensin II 
receptors. Nature. 544:327-32 
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biology and biochemistry categories. 
 
 
 
 
